|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-1-19
|
|
pubmed:abstractText |
The effect of CYP2C9 and vitamin K epoxide reductase complex subunit 1 (VKORC1) genotypes was evaluated for the early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1744-6872
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
103-12
|
|
pubmed:meshHeading |
pubmed-meshheading:19077919-Anticoagulants,
pubmed-meshheading:19077919-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:19077919-Asian Continental Ancestry Group,
pubmed-meshheading:19077919-Blood Coagulation,
pubmed-meshheading:19077919-Cohort Studies,
pubmed-meshheading:19077919-Dose-Response Relationship, Drug,
pubmed-meshheading:19077919-Female,
pubmed-meshheading:19077919-Genotype,
pubmed-meshheading:19077919-Heart Valve Prosthesis Implantation,
pubmed-meshheading:19077919-Heart Valves,
pubmed-meshheading:19077919-Heterozygote,
pubmed-meshheading:19077919-Humans,
pubmed-meshheading:19077919-International Normalized Ratio,
pubmed-meshheading:19077919-Male,
pubmed-meshheading:19077919-Middle Aged,
pubmed-meshheading:19077919-Mixed Function Oxygenases,
pubmed-meshheading:19077919-Polymorphism, Genetic,
pubmed-meshheading:19077919-Warfarin
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement.
|
|
pubmed:affiliation |
Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
